drugset / Trial / NCT05345938
A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia
NaSingle-groupOpen-labelTreatment
Summary
This is a multi-center, open-label, single-arm, phase I/II study to evaluate the safety, tolerability, efficacy, and pharmacokinetics of mitoxantrone hydrochloride liposome injection in subjects with acute myeloid leukemia (AML).
Timeline
- Start
- 2022-06-14
- Primary completion
- 2022-11-19
- Completion
- 2022-11-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mitoxantrone | Small molecule | 30 mg/m2 | Intravenous |
| Subject | Mitoxantrone | Small molecule | 36 mg/m2 | Intravenous |
| Subject | Mitoxantrone | Small molecule | 40 mg/m2 | Intravenous |